Kala Pharmaceuticals, Inc. (KALA)

NASDAQ: KALA · IEX Real-Time Price · USD

6.75

-0.07 (-0.95%)

At close: May 2, 2024, 4:00 PM

6.82

+0.07 (0.96%)

After-hours: May 3, 2024, 6:34 PM EDT

Kala Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016	2015
Market Capitalization	20	19	58	79	380	127	165	453	-	-
Market Cap Growth	-	-67.46%	-26.91%	-79.15%	198.27%	-22.87%	-63.55%	-	-	-
Enterprise Value	5	4	30	65	328	143	82	357	-36	4
PE Ratio	-0.45	-0.45	-1.29	-0.56	-3.64	-1.35	-2.48	-10.74	-	-
PS Ratio	-	-	14.88	7.05	59.76	20.99	-	-	-	-
PB Ratio	2.63	2.51	3.05	4.72	3.80	4.29	1.57	5.06	-	-
P/FCF Ratio	-0.66	-0.66	-0.73	-0.73	-4.10	-1.36	-2.97	-13.11	-	-
P/OCF Ratio	-0.68	-0.68	-0.73	-0.73	-4.19	-1.37	-3.05	-13.30	-	-
EV/Sales Ratio	-	-	7.81	5.81	51.49	23.58	-	-	-	87.27
EV/EBITDA Ratio	-0.12	-0.12	-0.83	-0.49	-3.53	-1.72	-1.31	-8.81	1.12	-0.25
EV/EBIT Ratio	-0.12	-0.12	-0.81	-0.49	-3.42	-1.67	-1.29	-8.68	1.11	-0.24
EV/FCF Ratio	-0.15	-0.15	-0.38	-0.60	-3.54	-1.52	-1.46	-10.33	1.31	-0.26
Debt / Equity Ratio	4.84	4.84	2.26	4.77	1.01	3.41	0.95	0.21	-0.11	-0.17
Debt / EBITDA Ratio	-1.01	-1.01	-1.17	-0.61	-1.09	-1.22	-1.59	-0.46	-0.30	-0.62
Debt / FCF Ratio	-1.27	-1.27	-0.54	-0.74	-1.09	-1.08	-1.79	-0.54	-0.35	-0.64
Quick Ratio	6.10	6.10	2.74	2.93	7.34	3.92	10.76	7.71	8.22	1.07
Current Ratio	6.34	6.34	3.35	3.32	7.71	4.26	10.41	7.75	8.23	1.38
Asset Turnover	0	0	0.04	0.06	0.03	0.04	0	0	0	-
Interest Coverage	-6.26	-6.26	-5.17	-16.02	-11.15	-10.13	-19.14	-40.42	-42.24	-26.62
Return on Equity (ROE)	-282.80%	-282.80%	952.00%	-209.50%	-87.60%	-174.60%	-86.60%	1063.50%	45.90%	-
Return on Assets (ROA)	-66.00%	-66.00%	-48.60%	-73.30%	-43.90%	-54.60%	-52.80%	-55.10%	-121.10%	-
Return on Capital (ROIC)	-88.81%	-88.81%	-132.41%	-134.28%	-47.90%	-67.41%	-31.66%	-36.81%	41.83%	34.02%
Earnings Yield	-213.82%	-223.85%	-77.38%	-179.93%	-27.44%	-74.02%	-40.38%	-9.31%	-	-
FCF Yield	-144.36%	-151.13%	-136.56%	-137.57%	-24.37%	-73.79%	-33.70%	-7.63%	-	-
Buyback Yield / Dilution	-59.94%	-59.94%	-15.50%	-25.67%	-53.11%	-27.87%	-135.20%	-862.80%	-5.46%	-
Total Shareholder Return	-59.94%	-59.94%	-15.50%	-25.67%	-53.11%	-27.87%	-135.20%	-862.80%	-5.46%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).